CancerVax’s recent in vitro data on mRNA based cancer immunotherapy puts fresh attention on how investors think about BioNTech (NasdaqGS:BNTX), another player working with mRNA and lipid nanoparticle ...
Source LinkCancerVax’s recent in vitro data on mRNA based cancer immunotherapy puts fresh attention on how investors think about BioNTech (NasdaqGS:BNTX), another player working with mRNA and lipid nanoparticle ...
Source Link
Comments